U.S. Fertility Clinics Market

Report Code: HLC209B

Publish Date: Jul 2023

Publisher: BCC Publishing

Category: Health Maintenance

Download Report Overview

Single User License: $4650

Member Price: FREE

EXPLORE OFFERS

Explore Our Services

Already a member? Login to access this report free.

Report Highlights

The U.S. market for fertility clinic services is estimated to increase from $8.9 billion in 2023 to reach $16.8 billion by 2028, at a compound annual growth rate (CAGR) of 13.6% from 2023 through 2028.

Report Includes

  • 37 tables
  • An up-to-date overview and analysis of the U.S. market for fertility clinic services
  • Analyses of the regional market trends, with historical market revenue data (sales figures) for 2020-2022, estimates for 2023, and projections of compound annual growth rates (CAGRs) through 2028
  • Discussion of the major growth drivers, industry-specific challenges, technology advancements, and the U.S. regulations and policies for fertility clinic services, which will shape the market as a basis for projecting demand in the next few years (2023-2028)
  • Estimation of the actual market size and revenue forecast for the U.S. fertility clinics market, and corresponding market share analysis based on the type of service and end-user
  • Discussion on cause of infertility and stages of fertility treatment along with the improved safety and efficacy of assisted reproductive technology
  • Examination of the critical market characteristics of the fertility market, including technological developments, the value chain, market dynamics, and key market trends
  • Insight into the recent structure of the industry, regulatory aspects, increasing investment on R&D activities, market development strategies, and company value share analysis
  • Profile descriptions of the major fertility clinics corporations, including Boston IVF LLC, CNY Fertility Center, NYU Langone Fertility Center, Shady Grove Fertility (SGF), Weill Cornell Medicine, and the UCSF Center for Reproductive Health (CRH)

Report Scope

The scope of this report is broad and covers emerging trends in the U.S. fertility clinic market. No other geographic regions are covered. This report segments the U.S. fertility clinic market into assisted reproductive technology, diagnostic services and surgeries.

This report highlights the current and future market potential and provides a detailed analysis of the market’s drivers, challenges and opportunities. For market estimates, data has been provided for 2020, 2021 and 2022 (as the base year), along with a forecast for 2028. The report also analyzes the market shares of leading companies and includes profiles of the major players in the market. It also analyzes the impact of the COVID-19 pandemic on the U.S. fertility clinic market.

Report Synopsis

Report Metrics Details
Base year considered 2022
Forecast period considered 2023-2028
Base year market size $7.9 billion
Market size forecast $16.8 billion
Growth rate CAGR of 13.6% from 2023 to 2028
Units considered $ Millions
Segments covered By Type of Service and End User
Key Market Drivers
  • Age and Infertility
  • Single Mothers
  • Obesity
  • Cultural Shifts
  • LGBTQ Community
  • Reimbursement and Benefits
Companies studied
BOSTON IVF LLC.BRIGHAM AND WOMEN'S HOSPITAL
CNY FERTILITY CENTERFERTILITY CENTER OF ILLINOIS
MASSACHUSETTS GENERAL HOSPITAL FERTILITY CENTERMAYO CLINIC ASSISTED REPRODUCTIVE TECHNOLOGIES
NEW HOPE FERTILITY CENTERNYU LANGONE FERTILITY CENTER
REPRODUCTIVE MEDICINE ASSOCIATES OF NEW JERSEYSHADY GROVE FERTILITY-ROCKVILLE
UCSF CENTER FOR REPRODUCTIVE HEALTH
Need a custom data table, graph, region, segment, companies or complete report? CUSTOMIZE NOW

Frequently Asked Questions (FAQs)

The U.S. Fertility Clinic Services is valued at $7.9 billion in 2022 and is forecasted to grow at a CAGR of 13.6% to reach a value of $16.8 billion in 2028.
The key factors driving the growth of the U.S. Fertility Clinics market includes.
  • Increasing Prevalence of infertility.
  • Single moms on the rise.
  • Cultural shifts and increasing LGBT community.
  • Reimbursement benefit trends.
The U.S. Fertility Clinics market is segmented on the basis of services type-Assisted reproductive technology services, diagnostic services and surgeries. And on the basis of technology, ART is segmented into IVF, donor eggs, donor sperm, surrogacy and gamete intrafallopian transfer and diagnostic services are segmented into hormone evaluation, semen analysis and new patient consultations. Based on end- user, market is segmented into clinics and research institutes and hospitals.
Assisted reproductive technology (ART) will dominate the market by the end of 2028.
Key companies in the market includes CNY Fertility, Shady Grove Fertility, Boston IVF, LLC, Reproductive Medicine associate (RMA) and NYU Langone.

Analyst Credentials

BCC Research Team possesses expertise and experience in life and physical science domains. They specialize in offering valuable business insights, including industry analysis, competitor intelligence, strategic and financial analysis, and opportunity assessment. The team has in-depth knowledge of various sectors, including healthcare, biotechnology, pharmaceuticals, IT, automation, advanced materials, and energy. They are proficient in qualitative and quantitative market intelligence providing clients with actionable insights. With a vast understanding of the competitive landscape, the team can support clients in making data-driven decisions to help them achieve a competitive edge in their respective markets.

Let us assist you! Our analysts are ready to tailor this report to your specific need. Talk to Our Analyst

Table of Contents

All reports provided in PDF format. For shared licensing options (5+ Users), please call a representative at (+1) 781-489-7301 or contact us at info@bccresearch.com
Title/Chapter NamePagesMember Price
Full Report: U.S. Fertility Clinics Market89Free
Chapter- 1: Introduction5Free
Chapter- 2: Summary and Highlights3Free
Chapter- 3: Market Outlook1Free
Chapter- 4: Market Overview5Free
Chapter- 5: Emerging Trends in the U.S. Fertility Clinic Market 5Free
Chapter- 6: Market Dynamics13Free
Chapter- 7: U.S. Fertility Clinics Market by Type9Free
Chapter- 8: U.S. Market for Fertility Drugs3Free
Chapter- 9: U.S. Fertility Clinics Market by End User3Free
Chapter- 10: Regulatory Aspects4Free
Chapter- 11: Competitive Landscape5Free
Chapter- 12: Company Profiles33Free
Published - Jan-2018| Analyst - BCC Research Reference Staff| Code - HLC209A

Report Highlights

The market for fertility clinics in the US should reach a value of $3.6 billion in 2017 and is expected to grow to $4.5 billion by 2022 at a compound annual growth rate (CAGR) of 4.6% for the period of 2017-2022.

Report Includes

  • An overview of the US market for fertility clinics
  • Analyses of global market trends, with data from 2012 through 2016, estimates for 2017, and projections of compound annual growth rates (CAGRs) through 2022
  • Examination of the critical market characteristics of the fertility market, including technological developments, the value chain, market dynamics, and key market trends
  • Market breakdowns by diagnostics services and assisted reproductive technology
  • Coverage of major government regulations, recent industry developments, and the competitive landscape
  • Information on leading companies, including Integramed, New Hope Fertility Center, Reproductive Medicine Associates Of New Jersey and Colorado Center of Reproductive Medicine

Related Reports

Human Reproductive Technologies: Products and Global Markets

Published - Aug 2022 | Publisher - BCC Publishing | Code - HLC017E

The global market for human reproductive technologies and products is valued at $16.1 billion in 2021 and is estimated to grow from $17.1 billion in 2022 to $24 billion in 2027 with a compound annual growth rate (CAGR) of 7% for the period of 2022-2027.

Pharmaceuticals for Women's Health: Global Markets

Published - Sep 2020 | Publisher - BCC Publishing | Code - PHM203B

The global market for women’s health therapeutics should grow from $31.5 billion in 2019 to $41.2 billion by 2025, at a compound annual growth rate (CAGR) of 4.7% for the period of 2019-2025.

Drugs for Infertility: Global Markets to 2022

Published - Apr 2018 | Publisher - BCC Research Reference Staff | Code - PHM194A

The global market for drugs for infertility should reach $4.2 billion by 2022 from $3.4 billion in 2017 at a compound annual growth rate (CAGR) of 4.3%, from 2017 to 2022.

Recent Reports

Surgical Equipment: Technologies and Global Markets

Published - Dec 2024 | Publisher - BCC Publishing | Code - HLC154C

The global market for surgical equipment and technologies was valued at $37.6 billion in 2023. This market is expected to grow from $40.0 billion in 2024 to $56.6 billion by 2029, at a compound annual growth rate (CAGR) of 7.2% from 2024 to 2029.

Conventional and Alternative Pain Treatment Markets

Published - Nov 2024 | Publisher - Partha Sarathi Das | Code - HLC266B

The global market for conventional and alternative pain treatment is expected to grow from $96.2 billion in 2024 and is projected to reach $144.2 billion by the end of 2029, at a compound annual growth rate (CAGR) of 8.4% during the forecast period of 2024 to 2029.

CRISPR Technology: Global Markets

Published - Oct 2024 | Publisher - BCC Publishing | Code - HLC258C

The global market for CRISPR technology was valued at $3.4 billion in 2023. This market is expected to grow from $3.8 billion in 2024 to $7.5 billion by the end of 2029, at a compound annual growth rate (CAGR) of 14.4% from 2024 to 2029.

Chronic Disease Management: Therapeutics, Device Technologies and Global Markets

Published - Oct 2024 | Publisher - BCC Publishing | Code - HLC239C

The global market for chronic disease management therapeutics and device technologies was valued at $675.0 billion in 2023. It is projected to grow from $726.3 billion in 2024 to $1.1 trillion by 2029, at a compound annual growth rate (CAGR) of 8.1% from 2024 through 2029.

Medical Devices: Technologies and Global Markets

Published - Oct 2024 | Publisher - Partha Sarathi Das | Code - HLC170F

The global market for medical devices reached $739.6 billion in 2023. It is expected to grow from $810.4 billion in 2024 to $1.3 trillion by the end of 2029, at a compound annual growth rate (CAGR) of 9.8% from 2024 through 2029.

Top Trending Reports

Single-use Technologies for Biopharmaceuticals: Global Markets

Published - Nov 2024 | Publisher - BCC Publishing | Code - BIO099F

The global market for single-use technologies for biopharmaceuticals is expected to grow from $6.5 billion in 2024 and is projected to reach $11.2 billion by the end of 2029, at a compound annual growth rate (CAGR) of 11.6% during the forecast period of 2024 to 2029.

Cell and Gene Therapy Tools, and Reagents: Global Markets

Published - Nov 2024 | Publisher - BCC Publishing | Code - BIO208C

The global market for Cell and Gene Therapy (CGT) Tools and Reagents is estimated to increase from $10.0 billion in 2024 to reach $16.7 billion by 2029, at a compound annual growth rate (CAGR) of 10.8% from 2024 through 2029.

Medical Devices Industry: Competitive Landscape

Published - Nov 2024 | Publisher - BCC Publishing | Code - MDS010C

The global market for medical devices is estimated to increase from 810.4 billion in 2024 to reach $1.3 trillion by 2029, at a compound annual growth rate (CAGR) of 9.8% from 2024 through 2029.

Global Market Opportunities and Competitive Landscape for CDMO

Published - Nov 2024 | Publisher - BCC Publishing | Code - PHM238B

The global CDMO market was valued at $128.0 billion in 2023. This market is expected to grow from $136.6 billion in 2024 to $191.6 billion by the end of 2029, at a compound annual growth rate (CAGR) of 7.0% from 2024 to 2029.

Chronic Disease Management: Therapeutics, Device Technologies and Global Markets

Published - Oct 2024 | Publisher - BCC Publishing | Code - HLC239C

The global market for chronic disease management therapeutics and device technologies was valued at $675.0 billion in 2023. It is projected to grow from $726.3 billion in 2024 to $1.1 trillion by 2029, at a compound annual growth rate (CAGR) of 8.1% from 2024 through 2029.

Become A Member

BCC Research offers a comprehensive library of reports, granting members unlimited access to data, insights, and market intelligence for informed business decisions, while actively supporting members in their evolving journeys and prioritizing high-quality, relevant topics based on continuous engagement with the research community.

Find Out More

Custom Consulting

BCC Research emphasizes the importance of organizations leveraging highly customized market insights aligned with specific strategic business objectives through direct engagement with primary sources and proprietary forecasting models for profitable decision-making in maximizing growth opportunities and minimizing risks.

Customize Now

Scorecard

The Venture Scorecard provides commercialization offices and decision makers with expert analysis, offering strategic insights crucial for aligning objectives with market realities at various stages of commercializing new products or evaluating investment opportunities, from opportunity assessment to growth planning.

Find Out More

Innovation Spotlight

Our industry experts offer strategic guidance to maximize the market potential of commercialized products, patents, and IP by providing insights into market trends, competitive dynamics, and effective positioning, using the Innovation Spotlight service for enhanced exposure to thought leaders and the wider community.

Find Out More
U.S. Fertility Clinics Market
Sample Report